| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.007 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |